News tagged with american society of clinical oncology
Related topics: cancer , cancer patients , chemotherapy
Benefits of prostate-specific antigen testing remain unclear
(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, ...
Cancer
Jul 20, 2012 |
not rated yet |
3
|
ASCO: Continuing avastin with 2nd-line chemo ups survival
(HealthDay) -- Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal ...
Cancer
Jun 05, 2012 |
not rated yet |
0
ASCO: Trametinib improves survival in metastatic melanoma
(HealthDay) -- For patients with metastatic melanoma with activating mutations in serine-threonine protein kinase B-RAF (BRAF), treatment with the oral selective MEK inhibitor trametinib is associated with ...
Cancer
Jun 05, 2012 |
not rated yet |
0
New US legislation aims to curb cancer drug shortages (Update)
A critical shortage of generic drugs in the United States, particularly in cancer care, could be curbed with legislation now being hammered out by the US House and Senate, doctors said on Monday.
Medications
Jun 04, 2012 |
not rated yet |
0
New immune therapy shows promise in kidney cancer
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Cancer
Jun 04, 2012 |
not rated yet |
0
Drug combination highly effective for newly diagnosed myeloma patients
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yester ...
Cancer
Jun 04, 2012 |
not rated yet |
0
|
Older drug for advanced breast cancer beat newer, pricier meds
(HealthDay) -- Even in the field of cancer treatment, sometimes newer isn't necessarily better.
Cancer
Jun 04, 2012 |
not rated yet |
0
|
After chest radiation, girls at greater risk for early breast cancer: study
(HealthDay) -- Girls who receive radiation to the chest to treat childhood cancer, even those getting lower doses, have a high risk of developing breast cancer at a young age, according to a new study.
Cancer
Jun 04, 2012 |
not rated yet |
0
Ginseng fights fatigue in cancer patients, study finds
High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had ...
Cancer
Jun 04, 2012 |
not rated yet |
0
Leukemia deadlier for teens, young adults than younger kids: study
(HealthDay) -- Teenagers and young adults with acute lymphoblastic leukemia, a cancer of the blood and bone marrow, are more likely to relapse and less likely to survive than younger children with the disease, ...
Cancer
Jun 02, 2012 |
not rated yet |
0
Drug cocktail boosts ovarian cancer survival time
A drug cocktail that combines chemotherapy with Avastin was shown to double the amount of time patients lived without progression of ovarian cancer, according to research released Saturday.
Cancer
Jun 02, 2012 |
not rated yet |
0
Researchers discover a DNA marker may indicate differences in breast cancer
Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is not experienced the same way with African American ...
Cancer
Jun 02, 2012 |
not rated yet |
0
Combination treatment with lapatinib and pazopanib doesn't improve outcomes for patients with IBC
Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting ...
Cancer
Jun 01, 2012 |
not rated yet |
0
Study reports first success of targeted therapy in type of non-small cell lung cancer
A novel compound has become the first targeted therapy to benefit patients with the most common genetic subtype of lung cancer, an international clinical trial led by scientists at Dana-Farber Cancer Institute and other institutions ...
Cancer
May 31, 2012 |
5 / 5 (1) |
0
'Just do it!' not good enough for cancer patients, researchers say
Exercise generally helps the nation's 12 million cancer survivors, but researchers are still working toward being able to prove, with scientific certainty, that prescriptions for daily yoga or 20 minutes of walking will likely ...
Cancer
May 30, 2012 |
not rated yet |
0
